Mergers & Acquisitions - Biosimilars

Filter

Current filters:

Biosimilars

Popular Filters

Merck KGaA may look to biosimilars and acquisitions for growth

Merck KGaA may look to biosimilars and acquisitions for growth

12-05-2014

German pharma and chemical major Merck KGaA has said it is planning to invest in innovations to ensure…

BiosimilarsLicensingMerck KGaAMergers & AcquisitionsPharmaceutical

Epirus to acquire Zalicus, creating a publicly-traded biosimilars enterprise

16-04-2014

Boston-based privately-held Epirus Biopharmaceuticals, focused on the global development and commercialization…

BiosimilarsBiotechnologyEPIRUS BiopharmaceuticalsMergers & AcquisitionsZalicus

GVK BIO to acquire US CRO Aragen Bioscience

30-01-2014

Asia’s leading small-molecule contract research organization (CRO), GVK BIO, has reached agreement…

Aragen BioscienceBiosimilarsGVK BIOMergers & AcquisitionsPharmaceutical

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

31-12-2013

China’s Walvax Biotech has revealed it plans to acquire a controlling 64% equity stake in Shanghai’s…

Asia-PacificBiosimilarsBiotechnologyChinaMergers & AcquisitionsOncology

Back to top